Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors

Journal of Virology

Volumn 75, Issue 9, 2001, Pages 4129-4138

  Christodoulopoulos, I ^a   Cannon, P M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; VIRUS FUSION PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENE MAPPING; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STABILITY; SEQUENCE HOMOLOGY; VIRUS PARTICLE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TRANSFORMED; CYTOPLASM; GENETIC VECTORS; HELA CELLS; HIV-1; HOMINIDAE; HUMANS; LENTIVIRUS; LEUKEMIA VIRUS, GIBBON APE; LEUKEMIA VIRUS, MURINE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; VIRAL ENVELOPE PROTEINS; VIRION;

EID: 0035047142     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.9.4129-4138.2001     Document Type: Article

References (68)

1. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A
2. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable pre-packaging cell lines
3. Receptor-binding domain of murine leukemia virus envelope glycoproteins
4. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
5. Retroviral vectors for human gene therapy
6. Bone marrow stromal cells as targets for gene therapy of hemophilia A
7. High-efficiency gene transfer into mammalian cells: Generation of helper-free recombinant retrovirus with broad mammalian host range
8. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
9. Granulocytic leukemia in whitehanded gibbons
10. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains
11. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus
12. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: Targeting of a cytotoxic gene by ligand display
13. Mutational analysis of the envelope gene of Moloney murine leukemia virus
14. Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus
15. Role of variable regions A and B in the receptor binding domain of amphotropic murine leukemia virus envelope protein
16. Naturally occurring murine leukemia viruses in wild mice: Characterization of a new "amphotropic" class
17. A new class of murine leukemia virus associated with development of spontaneous lymphomas
18. Site-directed mutagenesis by overlap extension using polymerase chain reaction
19. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles
20. Viral entry and receptors
21. + lymphoid cells
22. Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein
23. Cleavage of the murine leukemia virus transmembrane Env protein by human immunodeficiency virus type 1 protease: Transdominant inhibition by matrix mutations
24. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope
25. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range
26. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments
27. Demonstration of biological activity of a murine leukemia virus of New Zealand Black mice
28. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins
29. Gene transfer to human cells using retrovirus vectors produced by a new polytropic packaging cell line
30. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses
31. + cells
32. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus
33. Cell-surface receptors for retroviruses and implications for gene transfer
34. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
35. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry
36. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
37. Gene transfer by retrovirus vectors occurs in cells that are actively replicating at the time of infection
38. Stable gene transfer to the nervous system using a non-primate lentiviral vector
39. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
40. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells
41. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
42. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
43. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid
44. Topography of murine leukemia virus envelope proteins: Characterization of transmembrane components
45. Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies
46. Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors
47. pH-independent Moloney murine leukemia virus ecotropic envelope-mediated cell fusion: Implications for the role of the R peptide and p12E TM domain in viral entry
48. Retrovirus vectors bearing Jaagsiekte sheep retrovirus Env transduce human cells by using a new receptor localized to chromosome 3p21.3
49. Characterization of a highly oncogenic murine leukemia virus from wild mice
50. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein
51. Evidence for cooperation between murine leukemia virus Env molecules in mixed oligomers
52. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus
53. Conditional expression of the vesicular stomatitis virus glycoprotein gene in Escherichia coli
54. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells
55. Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage
56. A transient three-plasmid expression system for the production of high titer retroviral vectors
57. Enhancement of gene transfer efficiency into human cancer cells by modification of retroviral vectors and addition of chemicals
58. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1
59. Retroviral pseudotypes produced by rescue of Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses
60. Simian sarcoma-associated virus fails to infect Chinese hamster cells despite the presence of functional gibbon ape leukemia virus receptors
61. Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R
62. Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector
63. Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the Gag and Pol proteins of Moloney murine leukemia virus
64. Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines
65. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudo-typed with vesicular stomatitis virus G envelope protein
66. Functional interactions between monomers of the retroviral envelope protein complex
67. Functional domains in the retroviral transmembrane protein
68. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo